SUNPHARMA Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > sunpharma

Technical Analysis

Technical Strength: 7.5 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 59.6. According to RSI analysis, sunpharma is technically strong. 9.0 SUNPHARMA RSI Chart
MACD (?) MACD: 10.3 and Signal Line: 9.04. According to MACD analysis, sunpharma is technically strong. 8.0 SUNPHARMA MACD Chart
Simple Moving Average (?) According to simple moving average analysis, sunpharma is facing resistance from it's 200-day simple moving average at 589.408 and support level is at 523. 7.0 SUNPHARMA Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, sunpharma is facing resistance from it's 200-day exponential moving average at 581.7135 and support level is at 527. 7.0 SUNPHARMA Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.764. According to bollinger bands, sunpharma is technically strong. 7.0 SUNPHARMA Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 520.4604 and 510.1. Resistance level is 554.0. 6.5 SUNPHARMA Fibonacci Retracement Chart
Average True Range (?) ATR: 13.8 NA SUNPHARMA Average True Range Chart
Average Directional Index (?) ADX is 23.3 which means SUNPHARMA is in a trading range and there is no trend. NA SUNPHARMA Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
October 23, 2017
Open Price 536.05
High Price 543.5
Low Price 533.3
Close Price 540.4
Absolute Change 4.65
Percentage Change 0.868%
Weekly Change 1.07%
Monthly Change 3.99%
Yearly Change -27.3%
52-week high 759.0
52-week low 432.7
Corporate Actions
ExDate Purpose
September 18, 2017 AGM/DIV-RS 3.50 PER SHARE
September 08, 2016 AGM/DIV-RE 1/- PER SHARE
July 14, 2016 BUY BACK
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.606
Confidence in Beta1.9%
Market Capital Rs. 130058.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 8.9
TTM Price-to-Earnings (P/E) Ratio 60.7
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 23 October 2017: Deliverable Quantity:1.56e+06 NA SUNPHARMA Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 23 October 2017: Daily Volatility:0.3439 NA SUNPHARMA Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 23 October 2017: PCR_OI:0.813 PCR:0.451 NA SUNPHARMA PCR Chart
Option Pain (?) 23 October 2017: Max Pain:540.0 NA SUNPHARMA Option Pain Chart
Premium (?) 23 October 2017 Premium: -0.75 Futures OI:33888000.0 NA SUNPHARMA Premium Chart
Option_MAX_OI (?) 23 October 2017: Price:540.4 Put with maximum OI:480.0 Call with maximum OI:560.0 NA SUNPHARMA Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
October 26, 2017 539.65 33888000.0 7142.0 11730.0 540.4
November 30, 2017 542.5 6219200.0 2539.0 6498.0 540.4
December 28, 2017 541.05 56800.0 10.0 10.0 540.4

Announcements

October 13, 2017 SAcquisitionSun Pharmaceutical Industries Limited has informed the Exchange that one of the wholly owned subsidiaries of the Company has agreed to increase its shareholding in Ranbaxy Malaysia Sdn Bhd, Malaysia, by way of purchase of 666,985 shares of face value of MYR 1.00 each (equivalent to 8.3%) of Ranbaxy Malaysia Sdn Bhd.
October 05, 2017 SCredit RatingSun Pharmaceutical Industries Limited has informed the Exchange regarding Credit Rating of Commercial Paper of the Company by CRISIL
See all Announcements

Board Meetings

Date Meeting Date Purpose
July 26, 2017 August 11, 2017 TResultsTo consider and take on record the Unaudited Financial Results of the Company for the quarter ended June 30, 2017.
January 27, 2017 February 14, 2017 TResultsTo consider and take on record the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2016.
See all Board Meetings

SUNPHARMA is part of...

Index Weightage
NIFTY NA
CNXPHARMA NA

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 524.4 Rs. 528.9 Rs. 534.6 Rs. 539.1 Rs. 544.8 Rs. 549.3 Rs. 555